Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loren D Grossman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|May 31, 2002
New solutions for type 2 diabetes mellitus: the role of pioglitazoneLoren D Grossman
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic benefits of pioglitazone for treating patients with Type 2 diabetesLoren D Grossman, Christopher J Longo
Frontiers in Psychology|July 21, 2018
Improved Self-Esteem in Artists After Participating in the "Building Confidence and Self-Esteem Toolbox Workshop"Anita R Shack, Soumia Meiyappan, Loren D Grossman
Canadian Journal of Diabetes|April 14, 2018
Complementary and Alternative Medicine for Diabetes, Loren D Grossman, Robert Roscoe, et al.
Clinical Therapeutics|February 27, 2009
Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 yearsLoren D Grossman, Gelasio Parlan, Allan L Bailey, et al.
Clinical Therapeutics|June 18, 2003
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitusMatthias Herz, Don Johns, Jesus Reviriego, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|May 31, 2002
New solutions for type 2 diabetes mellitus: the role of pioglitazoneLoren D Grossman
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic benefits of pioglitazone for treating patients with Type 2 diabetesLoren D Grossman, Christopher J Longo
Frontiers in Psychology|July 21, 2018
Improved Self-Esteem in Artists After Participating in the "Building Confidence and Self-Esteem Toolbox Workshop"Anita R Shack, Soumia Meiyappan, Loren D Grossman
Canadian Journal of Diabetes|April 14, 2018
Complementary and Alternative Medicine for Diabetes, Loren D Grossman, Robert Roscoe, et al.
Clinical Therapeutics|February 27, 2009
Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 yearsLoren D Grossman, Gelasio Parlan, Allan L Bailey, et al.
Clinical Therapeutics|June 18, 2003
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitusMatthias Herz, Don Johns, Jesus Reviriego, et al.
Pageof 1